David B. Powers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David B. Powers has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Visakha Suresh
Department of Plastic and Reconstructive Surgery, Johns Hopkins School of Medicine, Baltimore, MD
7 shared publications - John Breeze
Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham, UK
5 shared publications Steven J. Lohmeier
Division of Plastic, Maxillofacial & Oral Surgery, Duke University Hospital, Durham, NC, United States; US Air Force Dental Corps, United States(1)
3 shared publications- Thomas Pepper
Queen Alexandra Hospital, Portsmouth, United Kingdom
3 shared publications Darin T. Johnston
Uniformed Services University, Craniomaxillofacial Trauma & Reconstruction, Oral & Maxillofacial Surgery, David Grant Medical Center, Travis AFB, California
2 shared publicationsDetlev Erdmann
Division of Plastic, Reconstructive, Maxillofacial and Oral Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina
2 shared publications
Latest Publications
- 28 October 2026
- Published by Springer Nature in Die MKG-Chirurgie
- p. 1-7
Ballistic maxillofacial injuries: a guide for the deployed surgeon
- 28 October 2026
- Published by Springer Nature in Die MKG-Chirurgie
- p. 1-7
Ballistic maxillofacial injuries: a guide for the deployed surgeon
- 4 September 2026
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 142 (6) , 909-916
Reassessing the nonoperative management of Ulysses S. Grant’s oral cancer
- 4 September 2026
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 142 (6) , 909-916
Reassessing the nonoperative management of Ulysses S. Grant’s oral cancer
- Open Access
- 3 March 2026
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 19 (1) , 14
Management Protocol for Ballistic and Other High-Energy Avulsive Facial Injuries—An Update for the 21st Century
High-energy ballistic and avulsive injuries to the face represent some of the most complex challenges in modern reconstructive surgery. Since Robertson and Manson’s 1999 management protocol, extensive military experience and technological advancements have transformed the treatment principles while preserving the core tenets of staged care. This updated review synthesizes evidence from 36 studies published since 2000, encompassing over two decades of global experience in both military and civilian trauma. Advances in damage-control resuscitation, wound decontamination, and early skeletal stabilization have improved survival and functional outcomes. Modern imaging—particularly intraoperative CT and navigation—enables the precise verification of the reduction and removal of retained fragments, while virtual surgical planning and patient-specific implants allow the accurate restoration of facial buttresses. Early vascularized tissue transfer has reduced contracture and infection rates. Adjuncts such as hyperbaric oxygen therapy, permissive hypotension, and advanced hemostatic agents further optimize recovery. The updated four-phase protocol—resuscitation, reconstitution, reconstruction, and rehabilitation—emphasizes early definitive repair, multidisciplinary collaboration, and the integration of digital planning. These refinements extend Robertson and Manson’s foundational principles into the era of precision surgery, achieving superior aesthetic and functional outcomes for patients with devastating facial injuries.
- 3 March 2026
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 19 (1) , 14
Open AccessManagement Protocol for Ballistic and Other High-Energy Avulsive Facial Injuries—An Update for the 21st Century
High-energy ballistic and avulsive injuries to the face represent some of the most complex challenges in modern reconstructive surgery. Since Robertson and Manson’s 1999 management protocol, extensive military experience and technological advancements have transformed the treatment principles while preserving the core tenets of staged care. This updated review synthesizes evidence from 36 studies published since 2000, encompassing over two decades of global experience in both military and civilian trauma. Advances in damage-control resuscitation, wound decontamination, and early skeletal stabilization have improved survival and functional outcomes. Modern imaging—particularly intraoperative CT and navigation—enables the precise verification of the reduction and removal of retained fragments, while virtual surgical planning and patient-specific implants allow the accurate restoration of facial buttresses. Early vascularized tissue transfer has reduced contracture and infection rates. Adjuncts such as hyperbaric oxygen therapy, permissive hypotension, and advanced hemostatic agents further optimize recovery. The updated four-phase protocol—resuscitation, reconstitution, reconstruction, and rehabilitation—emphasizes early definitive repair, multidisciplinary collaboration, and the integration of digital planning. These refinements extend Robertson and Manson’s foundational principles into the era of precision surgery, achieving superior aesthetic and functional outcomes for patients with devastating facial injuries.
- Open Access
- 8 January 2026
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 19 (1) , 4
Impact of Social Determinants of Health in the Treatment of Closed Nasal Bone Fractures
Study Design: Retrospective cohort study. Objective: To determine the association of social determinants of health with rates of closed nasal bone reduction. Methods: A retrospective analysis of the National Trauma Data Bank (NTDB) from 2011 to 2019 was performed, including only adult patients with isolated nasal bone fractures. Logistic regression modeling was used to estimate the association between closed nasal bone reduction and sociodemographic variables. Results: A total of 149,312 patients were included, with an average age of 50. Most patients were male (68%), White (72%), and non-Hispanic/Latino (77%), with Medicare insurance (25%). Most patients were cared for at non-university (54%) and non-profit hospitals (88%). A total of 39% were cared for at an ACS level 1 trauma center. Finally, 3.3% of the patients in this study underwent closed reduction. The odds of undergoing reduction decreased with increasing age (OR: 0.99, CI: (0.99, 0.99)). Compared to White patients, Asian and Black/African American patients had decreased odds of closed reduction (Asian: OR (CI) 0.71 (0.53, 0.95); Black: OR (CI): 0.71 (0.65, 0.79)). Patients with government insurance or who were uninsured had lower odds of closed reduction compared to private/commercial insurance, with Medicaid, Medicare, and not billed/self-pay odds ratios of 0.83 (CI: (0.76, 0.90)), 0.81 (CI: (0.73, 0.89)), and 0.79 (CI: (0.72, 0.86)), respectively. Conclusions: Social determinants of health are associated with differential rates of inpatient closed nasal bone reduction. Further studies in the outpatient setting are needed to determine if these associations remain consistent.
- 8 January 2026
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 19 (1) , 4
Open AccessImpact of Social Determinants of Health in the Treatment of Closed Nasal Bone Fractures
Study Design: Retrospective cohort study. Objective: To determine the association of social determinants of health with rates of closed nasal bone reduction. Methods: A retrospective analysis of the National Trauma Data Bank (NTDB) from 2011 to 2019 was performed, including only adult patients with isolated nasal bone fractures. Logistic regression modeling was used to estimate the association between closed nasal bone reduction and sociodemographic variables. Results: A total of 149,312 patients were included, with an average age of 50. Most patients were male (68%), White (72%), and non-Hispanic/Latino (77%), with Medicare insurance (25%). Most patients were cared for at non-university (54%) and non-profit hospitals (88%). A total of 39% were cared for at an ACS level 1 trauma center. Finally, 3.3% of the patients in this study underwent closed reduction. The odds of undergoing reduction decreased with increasing age (OR: 0.99, CI: (0.99, 0.99)). Compared to White patients, Asian and Black/African American patients had decreased odds of closed reduction (Asian: OR (CI) 0.71 (0.53, 0.95); Black: OR (CI): 0.71 (0.65, 0.79)). Patients with government insurance or who were uninsured had lower odds of closed reduction compared to private/commercial insurance, with Medicaid, Medicare, and not billed/self-pay odds ratios of 0.83 (CI: (0.76, 0.90)), 0.81 (CI: (0.73, 0.89)), and 0.79 (CI: (0.72, 0.86)), respectively. Conclusions: Social determinants of health are associated with differential rates of inpatient closed nasal bone reduction. Further studies in the outpatient setting are needed to determine if these associations remain consistent.
- 25 December 2025
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 64 (3) , 223-233
Transatlantic tools of the trade: Anglo-American instrumentation in oral and maxillofacial surgery
- 25 December 2025
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 64 (3) , 223-233
Transatlantic tools of the trade: Anglo-American instrumentation in oral and maxillofacial surgery
- 18 August 2025
- Published by Elsevier in Oral and Maxillofacial Surgery Clinics of North America
- Vol. 37 (4) , 585-590
Collaboration with Associated Surgical Specialties
- 18 August 2025
- Published by Elsevier in Oral and Maxillofacial Surgery Clinics of North America
- Vol. 37 (4) , 585-590
Collaboration with Associated Surgical Specialties
- 30 June 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (6) , e265649
Hyperbaric oxygen therapy for ballistic injuryinduced traumatic macroglossia
As a life-saving measure, in patients experiencing traumatic macroglossia, a definitive airway may be required to protect the airway until the oedema resolves. The utilisation of hyperbaric oxygen therapy (HBOT) has the potential to expedite the resolution of traumatic macroglossia and subsequent extubation of the patient. The following case report discusses a patient who experienced traumatic macroglossia following a ballistics injury in which HBOT was utilised. A man in his 20s experienced a gunshot to the mouth. On postoperative day (POD) 1 following surgical intervention which included the removal of the ballistic shrapnel, he experienced traumatic macroglossia and required emergent endotracheal intubation. He underwent HBOT sessions and was extubated on POD 4. The utilisation of HBOT may have utility in treating intubated patients with traumatic macroglossia to expedite the resolution of the macroglossia.
- 30 June 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (6) , e265649
Hyperbaric oxygen therapy for ballistic injuryinduced traumatic macroglossia
As a life-saving measure, in patients experiencing traumatic macroglossia, a definitive airway may be required to protect the airway until the oedema resolves. The utilisation of hyperbaric oxygen therapy (HBOT) has the potential to expedite the resolution of traumatic macroglossia and subsequent extubation of the patient. The following case report discusses a patient who experienced traumatic macroglossia following a ballistics injury in which HBOT was utilised. A man in his 20s experienced a gunshot to the mouth. On postoperative day (POD) 1 following surgical intervention which included the removal of the ballistic shrapnel, he experienced traumatic macroglossia and required emergent endotracheal intubation. He underwent HBOT sessions and was extubated on POD 4. The utilisation of HBOT may have utility in treating intubated patients with traumatic macroglossia to expedite the resolution of the macroglossia.
- Open Access
- 3 January 2025
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 18 (1) , 3
A Shift in Conceptual Thinking of Panfacial Fracture Sequencing: The Major Fragment Theory
Study Design: A literature review of relevant publications regarding panfacial fracture sequencing. Objective: To review the current landscape of sequencing of panfacial trauma and propose the utilization of the Major Fragment Theory when conventional sequencing techniques are inadequate. Methods: We conducted a review of existing literature on panfacial fracture management, focusing on sequencing techniques. Additionally, we analyzed unique fracture patterns to identify instances where conventional sequencing may be insufficient. Results: Existing literature emphasizes directional-based sequencing techniques for panfacial fracture reduction. However, unique fracture patterns often necessitate deviation from these sequences. The Major Fragment Theory suggests prioritizing the reduction of larger fragments over conventional sequencing, particularly when dealing with complex fractures. Conclusions: While directional-based sequencing techniques provide a valuable framework for panfacial fracture management and almost any approach can be utilized successfully, the Major Fragment Theory offers a complementary approach for cases where conventional sequencing falls short. Incorporating this theory into practice may enhance outcomes in the treatment of panfacial fractures.
- 3 January 2025
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 18 (1) , 3
Open AccessA Shift in Conceptual Thinking of Panfacial Fracture Sequencing: The Major Fragment Theory
Study Design: A literature review of relevant publications regarding panfacial fracture sequencing. Objective: To review the current landscape of sequencing of panfacial trauma and propose the utilization of the Major Fragment Theory when conventional sequencing techniques are inadequate. Methods: We conducted a review of existing literature on panfacial fracture management, focusing on sequencing techniques. Additionally, we analyzed unique fracture patterns to identify instances where conventional sequencing may be insufficient. Results: Existing literature emphasizes directional-based sequencing techniques for panfacial fracture reduction. However, unique fracture patterns often necessitate deviation from these sequences. The Major Fragment Theory suggests prioritizing the reduction of larger fragments over conventional sequencing, particularly when dealing with complex fractures. Conclusions: While directional-based sequencing techniques provide a valuable framework for panfacial fracture management and almost any approach can be utilized successfully, the Major Fragment Theory offers a complementary approach for cases where conventional sequencing falls short. Incorporating this theory into practice may enhance outcomes in the treatment of panfacial fractures.
- Open Access
- 24 October 2024
- Published by Georg Thieme Verlag KG in The Surgery Journal
- Vol. 10 (04) , e43-e52
Tracheal Replacement: A Scoping Review
Objective To summarize patient characteristics and outcomes for the historical and current methods of long-segment tracheal replacement in humans. Materials and Methods A single reviewer screened the abstracts and full texts using Covidence for file management. Studies published in English that reported human subjects with circumferential or near-circumferential (>270 degrees) cervical tracheal replacements were included. Articles with subjects treated with primary anastomosis alone, retracted articles, abstracts, expert opinion articles, and conference presentations were excluded. Results A total of 32 articles were included in the review reporting 156 cases of long-segment tracheal replacement including synthetic (alive at 1–8 years n = 6/64), regenerative medicine (dead at 15 days–55 months n = 4, not reported n = 6), cadaveric tracheal allograft (alive at 5 months–10 years n = 32/38), aortic allograft (alive at 6–85 months n = 12/16), free tissue transfer (alive at 6–108 months n = 13/21), allotransplantation (alive at 6–24 months n = 5/8), and vascular composite allograft (VCA) (alive at 20 months n = 1/1). Conclusion Silicone and Marlex prostheses have poor long-term outcomes. The cadaveric tracheal allograft can only replace near-circumferential tracheal defects and is therefore limited to benign tracheal pathology. Inadequate structural support plagues the aortic allograft and often requires numerous invasive procedures and maintenance of an intraluminal stent. A lack of mucociliary clearance exists in all methods of tracheal replacement except cadaveric tracheal allograft and VCA and can cause fatal mucous plugging and chronic pulmonary infections. VCA and allotransplantation require long-term immunomodulation therapy.
- 24 October 2024
- Published by Georg Thieme Verlag KG in The Surgery Journal
- Vol. 10 (04) , e43-e52
Open AccessTracheal Replacement: A Scoping Review
Objective To summarize patient characteristics and outcomes for the historical and current methods of long-segment tracheal replacement in humans. Materials and Methods A single reviewer screened the abstracts and full texts using Covidence for file management. Studies published in English that reported human subjects with circumferential or near-circumferential (>270 degrees) cervical tracheal replacements were included. Articles with subjects treated with primary anastomosis alone, retracted articles, abstracts, expert opinion articles, and conference presentations were excluded. Results A total of 32 articles were included in the review reporting 156 cases of long-segment tracheal replacement including synthetic (alive at 1–8 years n = 6/64), regenerative medicine (dead at 15 days–55 months n = 4, not reported n = 6), cadaveric tracheal allograft (alive at 5 months–10 years n = 32/38), aortic allograft (alive at 6–85 months n = 12/16), free tissue transfer (alive at 6–108 months n = 13/21), allotransplantation (alive at 6–24 months n = 5/8), and vascular composite allograft (VCA) (alive at 20 months n = 1/1). Conclusion Silicone and Marlex prostheses have poor long-term outcomes. The cadaveric tracheal allograft can only replace near-circumferential tracheal defects and is therefore limited to benign tracheal pathology. Inadequate structural support plagues the aortic allograft and often requires numerous invasive procedures and maintenance of an intraluminal stent. A lack of mucociliary clearance exists in all methods of tracheal replacement except cadaveric tracheal allograft and VCA and can cause fatal mucous plugging and chronic pulmonary infections. VCA and allotransplantation require long-term immunomodulation therapy.